HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03
HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03
Programme: Horizon Europe
9 projects · €31,499,194 total EU contribution (project-level) · 49 participating organizations · 15 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€31,499,194
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (8)
- Germany (7)
- Spain (7)
- France (7)
- BE (3)
- CH (3)
- Netherlands (3)
- AT (2)
- PT (2)
- UK (2)
- EL (1)
- HU (1)
- IE (1)
- LV (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- FONDAZIONE TELETHON ETS2 projects · IT
- ACHILLES THERAPEUTICS UK LIMITED1 projects · UK
- VETERINARY MEDICAL RESEARCH INSTITUTE1 projects · HU
- GENETHON1 projects · FR
- BIT BIO DISCOVERY GMBH1 projects · AT
- CELL THERAPY CATAPULT LIMITED1 projects · UK
- Cellularis Biomodels, Lda1 projects · PT
- CHUV1 projects · CH
- CNRS1 projects · FR
- CIEMAT1 projects · ES
- CINFERENCE GMBH1 projects · DE
- CROWDHELIX LIMITED1 projects · IE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
NOn-VIral gene modified STEM cell therapy NOVISTEM · 101071105 | HORIZON | €3,644,418 | €0 | Details |
Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies and advanced process control SMARTER · 101071054 | HORIZON | €1,364,281 | €818,438 | Details |
Targeting cancer with mutanome based stem cell vaccine MUTAVAC · 101071140 | HORIZON | €1,782,000 | €1,809,500 | Details |
FINE-TUNING T CELL NETWORKS OF EXHAUSTION BY SYNTHETIC SENSORS T-FITNESS · 101070740 | HORIZON | €4,387,826 | €946,651 | Details |
Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application X-PAND · 101070950 | HORIZON | €3,797,563 | €608,563 | Details |
Automated online monitoring & control to improve processes and decision making in cell and gene therapy manufacturing PAT4CGT · 101070922 | HORIZON | €3,617,784 | €324,938 | Details |
AI-powered platform for autologous iPSC manufacturing AiPSC · 101071188 | HORIZON | €3,999,225 | €1,282,267 | Details |
New Prime Editing and non-viral delivery strategies for Gene Therapy EdiGenT · 101070903 | HORIZON | €4,406,098 | €861,625 | Details |
Next-generation AAV vectors for liver-directed gene therapy AAVolution · 101071041 | HORIZON | €4,500,000 | €591,000 | Details |